Evidence map›Paper›PMID 33177790›Full record

ReviewWorld journal of gastroenterology2020

Role of gut microbiota via the gut-liver-brain axis in digestive diseases.

Jian-Hong Ding, Zhe Jin, Xiao-Xu Yang, Jun Lou, Wei-Xi Shan, Yan-Xia Hu, Qian Du, Qiu-Shi Liao, Rui Xie, Jing-Yu Xu

Open access · greenAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 3 pooled it
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 3 syntheses or guidelines pooled it, 168 citations in OpenAlex.

  1. Mucosal immune response in biology, disease prevention and treatment.Signal transduction and targeted therapy · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Iranian journal of microbiology · 2026
    Article
  6. Journal of pharmacopuncture · 2026
    Article
  7. Article
  8. Article
  9. Hepatoprotective Activity ofCurrent issues in molecular biology · 2026
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Frontiers in pharmacology · 2026
    Article
  16. Review
  17. A Review of Recent Advances in Fecal Microbiota Transplantation for the Treatment of Hepatic Encephalopathy.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  18. Article
  19. Article
  20. Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Jian-Hong DingDepartment of Gastroenterology, Affiliated Hospital to Zunyi Medical University, Zunyi 563003, Guizhou Province, China.
Zhe JinDepartment of Gastroenterology, Affiliated Hospital to Zunyi Medical University, Zunyi 563003, Guizhou Province, China.
Xiao-Xu YangDepartment of Gastroenterology, Affiliated Hospital to Zunyi Medical University, Zunyi 563003, Guizhou Province, China.
Jun LouDepartment of Gastroenterology, Affiliated Hospital to Zunyi Medical University, Zunyi 563003, Guizhou Province, China.
Wei-Xi ShanDepartment of Gastroenterology, Affiliated Hospital to Zunyi Medical University, Zunyi 563003, Guizhou Province, China.
Yan-Xia HuDepartment of Gastroenterology, Affiliated Hospital to Zunyi Medical University, Zunyi 563003, Guizhou Province, China.
Qian DuDepartment of Gastroenterology, Affiliated Hospital to Zunyi Medical University, Zunyi 563003, Guizhou Province, China.
Qiu-Shi LiaoDepartment of Gastroenterology, Affiliated Hospital to Zunyi Medical University, Zunyi 563003, Guizhou Province, China.
Rui XieDepartment of Gastroenterology, Affiliated Hospital to Zunyi Medical University, Zunyi 563003, Guizhou Province, China.
Jing-Yu XuDepartment of Gastroenterology, Affiliated Hospital to Zunyi Medical University, Zunyi 563003, Guizhou Province, China. xujingyu_gzzy@126.com.
Zunyi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut-brain axis is a bidirectional information interaction system between the central nervous system (CNS) and the gastrointestinal tract, in which gut microbiota plays a key role. The gut microbiota forms a complex network with the enteric nervous system, the autonomic nervous system, and the neuroendocrine and neuroimmunity of the CNS, which is called the microbiota-gut-brain axis. Due to the close anatomical and functional interaction of the gut-liver axis, the microbiota-gut-liver-brain axis has attracted increased attention in recent years. The microbiota-gut-liver-brain axis mediates the occurrence and development of many diseases, and it offers a direction for the research of disease treatment. In this review, we mainly discuss the role of the gut microbiota in the irritable bowel syndrome, inflammatory bowel disease, functional dyspepsia, non-alcoholic fatty liver disease, alcoholic liver disease, cirrhosis and hepatic encephalopathy via the gut-liver-brain axis, and the focus is to clarify the potential mechanisms and treatment of digestive diseases based on the further understanding of the microbiota-gut- liver-brain axis.

Indexed as

Enteric Nervous SystemGastrointestinal MicrobiomeIrritable Bowel SyndromeBrainHumansLiverDigestive diseasesGut-liver axisGut microbiotaHerbaceous medicationsMicrobiota-gut-brain axis

Identifiers

PMID33177790
PMCPMC7596643
OpenAlexW3095216271

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.